Insider Buying: National Health Investors (NYSE:NHI) Director Acquires 890 Shares of Stock

National Health Investors, Inc. (NYSE:NHI) Director Robert Mccabe, Jr. acquired 890 shares of the business’s stock in a transaction that occurred on Monday, June 15th. The stock was bought at an average cost of $71.65 per share, for a total transaction of $63,768.50. Following the completion of the purchase, the director directly owned 44,159 shares in the company, valued at $3,163,992.35. This represents a 2.06% increase in their position. The acquisition was disclosed in a filing with the SEC, which is available through the SEC website.

National Health Investors Stock Performance

National Health Investors stock traded down $1.37 during trading hours on Monday, reaching $70.73. 334,135 shares of the company were exchanged, compared to its average volume of 344,457. National Health Investors, Inc. has a 12 month low of $67.94 and a 12 month high of $91.38. The company has a current ratio of 8.20, a quick ratio of 8.20 and a debt-to-equity ratio of 0.83. The stock has a 50-day moving average of $77.29 and a 200 day moving average of $80.09. The firm has a market cap of $3.43 billion, a price-to-earnings ratio of 22.82, a PEG ratio of 3.87 and a beta of 0.52.

National Health Investors (NYSE:NHI) last released its earnings results on Monday, May 4th. The real estate investment trust reported $0.82 earnings per share for the quarter, missing analysts’ consensus estimates of $1.21 by ($0.39). National Health Investors had a return on equity of 9.82% and a net margin of 36.86%.The firm had revenue of $115.13 million for the quarter, compared to analyst estimates of $70.22 million. During the same period in the prior year, the firm earned $1.15 EPS. The firm’s revenue was up 28.9% on a year-over-year basis. National Health Investors has set its FY 2026 guidance at 4.740-4.790 EPS. As a group, research analysts anticipate that National Health Investors, Inc. will post 4.93 earnings per share for the current year.

National Health Investors Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, August 7th. Investors of record on Tuesday, June 30th will be issued a dividend of $0.92 per share. This represents a $3.68 annualized dividend and a yield of 5.2%. The ex-dividend date of this dividend is Tuesday, June 30th. National Health Investors’s dividend payout ratio (DPR) is currently 118.71%.

Wall Street Analysts Forecast Growth

Several analysts have weighed in on NHI shares. Truist Financial decreased their price objective on shares of National Health Investors from $89.00 to $81.00 and set a “buy” rating on the stock in a research note on Friday. Cantor Fitzgerald reiterated an “overweight” rating and issued a $94.00 target price on shares of National Health Investors in a research note on Wednesday, April 22nd. BMO Capital Markets decreased their price target on National Health Investors from $90.00 to $80.00 and set an “outperform” rating on the stock in a research report on Monday. Weiss Ratings cut National Health Investors from a “buy (b)” rating to a “buy (b-)” rating in a report on Friday. Finally, Wells Fargo & Company cut their price objective on National Health Investors from $84.00 to $79.00 and set an “equal weight” rating for the company in a research report on Monday, June 1st. One analyst has rated the stock with a Strong Buy rating, five have issued a Buy rating and two have given a Hold rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $84.57.

Institutional Inflows and Outflows

A number of large investors have recently added to or reduced their stakes in NHI. Militia Capital Management LLC acquired a new stake in shares of National Health Investors during the 1st quarter worth approximately $2,458,000. NewEdge Advisors LLC lifted its holdings in National Health Investors by 18.1% in the first quarter. NewEdge Advisors LLC now owns 12,046 shares of the real estate investment trust’s stock valued at $974,000 after buying an additional 1,844 shares during the period. Bank of America Corp DE lifted its holdings in National Health Investors by 20.0% in the first quarter. Bank of America Corp DE now owns 992,802 shares of the real estate investment trust’s stock valued at $80,278,000 after buying an additional 165,467 shares during the period. Janus Henderson Group PLC boosted its stake in National Health Investors by 14.9% in the first quarter. Janus Henderson Group PLC now owns 22,409 shares of the real estate investment trust’s stock valued at $1,812,000 after acquiring an additional 2,900 shares during the last quarter. Finally, Amundi grew its holdings in National Health Investors by 5.2% during the 1st quarter. Amundi now owns 24,866 shares of the real estate investment trust’s stock worth $2,011,000 after acquiring an additional 1,225 shares during the period. 62.51% of the stock is currently owned by institutional investors and hedge funds.

National Health Investors Company Profile

National Health Investors, Inc (NYSE: NHI) is a specialized real estate investment trust (REIT) focused on owning and financing high-quality healthcare and senior housing facilities in the United States. The company’s portfolio encompasses a diverse range of properties, including skilled nursing centers, assisted living and memory care communities, behavioral health facilities, dialysis clinics, and medical office buildings. NHI typically enters into long-term net-lease agreements with experienced healthcare operators, providing stable and predictable rental income streams while enabling its tenants to concentrate on delivering quality care.

Since its founding in 1991 and initial public offering later that year, National Health Investors has pursued a disciplined growth strategy centered on strategic acquisitions, joint ventures, and selective development.